Loxapine Succinate

琥珀酸洛沙平

Report date: 2023/03/16 10:39:39
NME

Base Information

Drug NameLoxapine Succinate
Drug Alias Name洛沙平琥珀酸盐LoxapinumLoxapina丁二酸洛沙平loxapina +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsSchizophreniaMigraine DisordersAsthma
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryUnited States
Original Approved Date1975/02/25
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesActavis A/S
China Registration ClassN/A

Develop Information

Active CompaniesPrasco LlcZhejiang Hisun Pharmaceutical Co Ltd
Inactive CompaniesMylan Pharmaceuticals IncAlexza Pharmaceuticals IncTeva Branded Pharmaceutical Products R&D Inc +[4] 
Active IndicationsSchizophrenia
Inactive IndicationsMigraine DisordersAsthma

Other Information

ATC CodeN05AH01
Related LinksWikipediaDrugBankKEGG